Mark McKenna from Prometheus Biosciences and Josh Kennedy-Smith from RTW Investments tell us about the white-knuckle ride that is building a pharmaceutical start-up, their passion for providing better care solutions for patients, the recent deal with Merck and the power of a strong partnership with your investor.

Host: Josh Baldwin, RTW Investments

Featuring: Mark McKenna, CEO of Prometheus Biosciences and Josh Kennedy-Smith, Managing Director; Research Analyst of RTW Investments.

FOLLOW US

Love our podcast? Follow us on LinkedIn at RTW Investments, LP and check out our website for the latest updates and insights.

To make sure you never miss an episode, you can subscribe to the RTW podcast on Spotify, Apple Podcasts, Amazon Music, and most other podcast platforms.

DISCLAIMER

Statements reflect RTW’s views and opinions as of the date hereof and not as of any future date. All expressions of opinion are subject to change without notice and are not intended to be a forecast of future events or results.

The power of partnership – Prometheus Biosciences

The RTW Podcast

The power of partnership – Prometheus Biosciences